Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 1 de 1
Filtre
Ajouter des filtres








Gamme d'année
1.
Braz. j. med. biol. res ; 44(8): 786-792, Aug. 2011. ilus, tab
Article Dans Anglais | LILACS | ID: lil-595714

Résumé

Tamoxifen has been associated with a reduction in the incidence of myocardial infarction. However, the effects of tamoxifen on coronary reactivity have not been fully elucidated. The objective of this study was to determine the effects of chronic treatment with tamoxifen on coronary vascular reactivity in spontaneously hypertensive rats (SHR). Female SHR were divided into four groups (N = 7 each): sham-operated (SHAM), sham-operated and treated with tamoxifen (10 mg/kg) by gavage for 90 days (TAMOX), ovariectomized (OVX), and ovariectomized and treated with tamoxifen (OVX+TAMOX). Mean arterial pressure (MAP), heart rate (HR), coronary perfusion pressure (CPP), and coronary vascular reactivity were measured. MAP and HR were reduced (9.42 and 11.67 percent, respectively) in the OVX+TAMOX group compared to the OVX group (P < 0.01). The coronary vascular reactivity of the OVX+TAMOX group presented smaller vasoconstrictor responses to acetylcholine (2-64 µg) when compared to the OVX group (P < 0.01) and this response was similar to that of the SHAM group. The adenosine-induced vasodilator response was greater in the TAMOX group compared to the SHAM and OVX groups (P < 0.05). Baseline CPP was higher in OVX+TAMOX and TAMOX groups (136 ± 3.6 and 130 ± 1.5 mmHg) than in OVX and SHAM groups (96 ± 2 and 119 ± 2.3 mmHg; P < 0.01). Tamoxifen, when combined with OVX, attenuated the vasoconstriction induced by acetylcholine and increased the adenosine-induced vasodilatory response, as well as reducing the MAP, suggesting beneficial effects of tamoxifen therapy on coronary vascular reactivity after menopause.


Sujets)
Animaux , Femelle , Rats , Vaisseaux coronaires/effets des médicaments et des substances chimiques , Hypertension artérielle/traitement médicamenteux , Modulateurs sélectifs des récepteurs des oestrogènes/pharmacologie , Tamoxifène/pharmacologie , Pression sanguine/effets des médicaments et des substances chimiques , Maladie des artères coronaires/prévention et contrôle , Circulation coronarienne/effets des médicaments et des substances chimiques , Vaisseaux coronaires/physiopathologie , Modèles animaux de maladie humaine , Hypertension artérielle/physiopathologie , Ovariectomie , Perfusion , Répartition aléatoire , Rats de lignée SHR
SÉLECTION CITATIONS
Détails de la recherche